INS and metabolic syndrome: IR is associated with obesity, T2DM, metabolic syndrome, hyperinsulinemia, hyperglycemia, dyslipidemia, etc. For example, hyperinsulinemia due to IR is associated with an increased risk of cancer, as insulin is closely associated with cancer progression.